Amisulpride in Schizophrenic Acute Phase Patients

Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

NCT00563017 ·Status: UNKNOWN ·Phase: NA

A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)

NCT01192867 ·Status: COMPLETED ·Phase: PHASE3

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

NCT01490086 ·Status: COMPLETED ·Phase: PHASE2

Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

NCT00463372 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia

NCT05964790 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)

NCT01235520 ·Status: COMPLETED ·Phase: PHASE3

A Study of Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)

NCT04010864 ·Status: UNKNOWN

A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects

NCT04839926 ·Status: UNKNOWN ·Phase: PHASE1

A Study of HS-10380 in Chinese Participants

NCT05480592 ·Status: UNKNOWN ·Phase: PHASE1

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia

NCT01051531 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy Volunteers

NCT01511510 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia

NCT00253136 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients

NCT00645372 ·Status: COMPLETED ·Phase: PHASE3

A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia

NCT01493726 ·Status: COMPLETED ·Phase: PHASE1

A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.

NCT00616798 ·Status: COMPLETED ·Phase: PHASE2

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

NCT00080327 ·Status: COMPLETED ·Phase: PHASE4

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

NCT02109562 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

NCT02873208 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone

NCT02019329 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer

NCT01185418 ·Status: COMPLETED

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

NCT00549718 ·Status: COMPLETED ·Phase: PHASE3

Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

NCT00283179 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia

NCT02624167 ·Status: COMPLETED ·Phase: PHASE2

A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics

NCT01685931 ·Status: COMPLETED ·Phase: PHASE4

Study of a Novel Antipsychotic ITI-007 in Schizophrenia

NCT01499563 ·Status: COMPLETED ·Phase: PHASE2